SKLADANY, Lubomir, Marian OLTMAN, Sona FRANKOVA, Sylvia DRAZILOVA, Petr HUSA, Jan SPERL, Vaclav HEJDA, Petr URBANEK, Svetlana ADAMCOVA-SELCANOVA, Martin JANICKO, Pavol KRISTIAN, Viera KUPCOVA, Marek RAC, Ivan SCHRETER, Ladislav VIRAG, Adriana LIPTAKOVA, Miriam ONDRASOVA and Peter JARCUSKA. Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics. International Journal of Public Health. Basel (Switzerland): Springer, 2020, vol. 65, No 9, p. 1723-1735. ISSN 1661-8556. Available from: https://dx.doi.org/10.1007/s00038-020-01496-y.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics
Authors SKLADANY, Lubomir (703 Slovakia), Marian OLTMAN (703 Slovakia, guarantor), Sona FRANKOVA (203 Czech Republic), Sylvia DRAZILOVA (703 Slovakia), Petr HUSA (203 Czech Republic, belonging to the institution), Jan SPERL (203 Czech Republic), Vaclav HEJDA (203 Czech Republic), Petr URBANEK (203 Czech Republic), Svetlana ADAMCOVA-SELCANOVA (703 Slovakia), Martin JANICKO (703 Slovakia), Pavol KRISTIAN (703 Slovakia), Viera KUPCOVA (703 Slovakia), Marek RAC (203 Czech Republic), Ivan SCHRETER (203 Czech Republic), Ladislav VIRAG (703 Slovakia), Adriana LIPTAKOVA (703 Slovakia), Miriam ONDRASOVA (703 Slovakia) and Peter JARCUSKA (203 Czech Republic).
Edition International Journal of Public Health, Basel (Switzerland), Springer, 2020, 1661-8556.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.380
RIV identification code RIV/00216224:14110/20:00116718
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00038-020-01496-y
UT WoS 000576627700002
Keywords in English Chronic HCV infection; HCV genotype; HCV liver disease; Czech Republic; Slovakia; Anti-HCV therapy
Tags 14110214, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/1/2021 13:35.
Abstract
Objectives The MOSAIC study gathered data on chronic hepatitis C virus (HCV) infection and its treatment in various countries worldwide. Here we summarise patient and HCV characteristics in the Czech Republic and Slovakia. Methods MOSAIC was an observational study that included patients with chronic HCV infection untreated at the time of enrolment. Study collected and descriptively analysed patient demographics, disease stage and viral characteristics. Data were collected between February 2014 to October 2014. Results Among 220 patients enrolled, 51.4% were treatment-naive. The most prevalent HCV genotype was G1 (78.4%), followed by G3 (19.7%). Higher prevalence of G1 was found in treatment-experienced patients (94.3%) compared to treatment-naive (63.4%). Most participants (67.7%) presented viral RNA load of >= 800,000 IU/mL. Liver cirrhosis was reported in 24.5% of patients. Higher HCV RNA load and duration of HCV infection correlated with the degree of liver fibrosis. Anti-HCV interferon-based treatments were initiated in 88.2% of participants. Conclusions The study confirmed significant changes in the HCV genotypes partition with G3 genotype rapidly increasing in both countries, with possible impact on the WHO eradication initiative and treatment selection.
PrintDisplayed: 4/9/2024 23:24